Antifibrotic effects of ZK14, a novel nitric oxidedonating biphenyldicarboxylate derivative, on rat HSC-T6 cells and CCI4-induced hepatic fibrosis
Aim: To study the pharmacologic effect of ZK14, a novel nitric oxide-donating biphenyldicarboxylate (DDB) derivative, on HSC-T6 cells and on CCI4-induced hepatic fibrosis. Methods: Inhibition of HSC-T6 cell growth by ZK14 was evaluated by MTT assay. The effect of ZK14 on the percentage of HSC-T6 cel...
Saved in:
Published in | Acta pharmacologica Sinica no. 1; pp. 27 - 34 |
---|---|
Main Author | |
Format | Journal Article |
Language | English |
Published |
2010
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!